Tetsuro Mazaki
Okayama University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tetsuro Mazaki.
Scientific Reports | 2015
Tetsuro Mazaki; Yasuyuki Shiozaki; Kentaro Yamane; Aki Yoshida; Mariko Nakamura; Yasuhiro Yoshida; Di Zhou; Takashi Kitajima; Masato Tanaka; Yoshihiro Ito; Toshifumi Ozaki; Akihiro Matsukawa
Osteochondral injuries remain difficult to repair. We developed a novel photo-cross-linkable furfurylamine-conjugated gelatin (gelatin-FA). Gelatin-FA was rapidly cross-linked by visible light with Rose Bengal, a light sensitizer, and was kept gelled for 3 weeks submerged in saline at 37°C. When bone marrow-derived stromal cells (BMSCs) were suspended in gelatin-FA with 0.05% Rose Bengal, approximately 87% of the cells were viable in the hydrogel at 24 h after photo-cross-linking, and the chondrogenic differentiation of BMSCs was maintained for up to 3 weeks. BMP4 fusion protein with a collagen binding domain (CBD) was retained in the hydrogels at higher levels than unmodified BMP4. Gelatin-FA was subsequently employed as a scaffold for BMSCs and CBD-BMP4 in a rabbit osteochondral defect model. In both cases, the defect was repaired with articular cartilage-like tissue and regenerated subchondral bone. This novel, photo-cross-linkable gelatin appears to be a promising scaffold for the treatment of osteochondral injury.
International Journal of Nanomedicine | 2013
Yasuyuki Shiozaki; Takashi Kitajima; Tetsuro Mazaki; Aki Yoshida; Masato Tanaka; Akihiro Umezawa; Mariko Nakamura; Yasuhiro Yoshida; Yoshihiro Ito; Toshifumi Ozaki; Akihiro Matsukawa
Purpose Bone defects and nonunions are major clinical skeletal problems. Growth factors are commonly used to promote bone regeneration; however, the clinical impact is limited because the factors do not last long at a given site. The introduction of tissue engineering aimed to deter the diffusion of these factors is a promising therapeutic strategy. The purpose of the present study was to evaluate the in vivo osteogenic capability of an engineered bone morphogenetic protein-4 (BMP4) fusion protein. Methods BMP4 was fused with a nanosized carrier, collagen-binding domain (CBD), derived from fibronectin. The stability of the CBD-BMP4 fusion protein was examined in vitro and in vivo. Osteogenic effects of CBD-BMP4 were evaluated by computer tomography after intramedullary injection without a collagen–sponge scaffold. Recombinant BMP-4, CBD, or vehicle were used as controls. Expressions of bone-related genes and growth factors were compared among the groups. Osteogenesis induced by CBD-BMP4, BMP4, and CBD was also assessed in a bone-defect model. Results In vitro, CBD-BMP4 was retained in a collagen gel for at least 7 days while BMP4 alone was released within 3 hours. In vivo, CBD-BMP4 remained at the given site for at least 2 weeks, both with or without a collagen–sponge scaffold, while BMP4 disappeared from the site within 3 days after injection. CBD-BMP4 induced better bone formation than BMP4 did alone, CBD alone, and vehicle after the intramedullary injection into the mouse femur. Bone-related genes and growth factors were expressed at higher levels in CBD-BMP4-treated mice than in all other groups, including BMP4-treated mice. Finally, CBD-BMP4 potentiated more bone formation than did controls, including BMP4 alone, when applied to cranial bone defects without a collagen scaffold. Conclusion Altogether, nanocarrier-CBD enhanced the retention of BMP4 in the bone, thereby promoting augmented osteogenic responses in the absence of a scaffold. These results suggest that CBD-BMP4 may be clinically useful in facilitating bone formation.
Acta Neurochirurgica | 2010
Yoshihisa Sugimoto; Yasuo Ito; Masao Tomioka; Tetsuya Shimokawa; Yasuyuki Shiozaki; Tetsuro Mazaki; Masato Tanaka
BackgroundCervical pedicle screws, when misplaced, tend to perforate laterally. One of the reasons for lateral perforation is vertebral rotation during screw insertion. However, actual vertebral rotation during pedicle screw insertion is unknown. In this study, we measured vertebral rotation during pedicle screw insertion in patients with cervical injury.MethodsWe inserted 76 pedicle screws into 38 vertebrae (C2 to C7) in 17 patients. All patients had some type of cervical injury. Screws were placed using intraoperative acquisition of data acquired with the isocentric C-arm fluoroscope (Iso-C3D) and computer navigation. We made screw holes using an image-guided awl, and we took images of cervical vertebrae in the neutral and rotational positions using navigation. Images of 76 insertions and rotational positions were taken while each cervical vertebra was under maximum stress at the time we were making the pedicle hole by awl.ResultsAverage cervical vertebra rotation was 10.6° (range 6 to 17) at C2, 9.1° (5 to 13) at C3, 7.8° (6 to 9) at C4, 6.7° (4 to 11) at C5, 4.9° (2 to 8) at C6, and 2.8° (0 to 4) at C7. Vertebrae in the upper and middle cervical spine rotated more than the lower cervical spine vertebrae. Of the 76 pedicle screws inserted into vertebrae between C2 and C7, 74 screws (97.4%) were classified as grade 1 (no pedicle perforation).ConclusionsIn this study, upper and middle cervical vertebrae in patients with neck injuries rotated more than the lower vertebrae. We should be especially careful of cervical rotation during screw insertion from C2 to C6, so as to prevent vertebral artery injury.
Scientific Reports | 2018
Kentaro Yamane; Tetsuro Mazaki; Yasuyuki Shiozaki; Aki Yoshida; Kensuke Shinohara; Mariko Nakamura; Yasuhiro Yoshida; Di Zhou; Takashi Kitajima; Masato Tanaka; Yoshihiro Ito; Toshifumi Ozaki; Akihiro Matsukawa
The treatment of spinal cord injury (SCI) is currently a significant challenge. Hepatocyte growth factor (HGF) is a multipotent neurotrophic and neuroregenerative factor that can be beneficial for the treatment of SCI. However, immobilized HGF targeted to extracellular matrix may be more effective than diffusible, unmodified HGF. In this study, we evaluated the neurorestorative effects of an engineered HGF with a collagen biding domain (CBD-HGF). CBD-HGF remained in the spinal cord for 7 days after a single administration, while unmodified HGF was barely seen at 1 day. When a gelatin-furfurylamine (FA) hydrogel was applied on damaged spinal cord as a scaffold, CBD-HGF was retained in gelatin-FA hydrogel for 7 days, whereas HGF had faded by 1 day. A single administration of CBD-HGF enhanced recovery from spinal cord compression injury compared with HGF, as determined by motor recovery, and electrophysiological and immunohistochemical analyses. CBD-HGF alone failed to improve recovery from a complete transection injury, however CBD-HGF combined with gelatin-FA hydrogel promoted endogenous repair and recovery more effectively than HGF with hydrogel. These results suggest that engineered CBD-HGF has superior therapeutic effects than naïve HGF. CBD-HGF combined with hydrogel scaffold may be promising for the treatment of serious SCI.
Asian Spine Journal | 2012
Yoshihisa Sugimoto; Yasuo Ito; Yasuyuki Shiozaki; Tetsuya Shimokawa; Tetsuro Mazaki
The diagnostic performance of helical computed tomography (CT) is excellent. However, some artifacts have been reported, such as motion, beam hardening and scatter artifacts. We herein report a case of motion-induced artifact mimicking cervical dens fracture. A 60-year-old man was involved in a motorcycle accident that resulted in cervical spinal cord injury and quadri plegia. Reconstructed CT images of the cervical spine showed a dens fracture. We assessed axial CT in detail, and motion artifact was detected.
Acta Medica Okayama | 2010
Yoshihisa Sugimoto; Yasuo Ito; Masao Tomioka; Tetsuya Shimokawa; Yasuyuki Shiozaki; Tetsuro Mazaki; Masato Tanaka
Acta Medica Okayama | 2010
Yoshihisa Sugimoto; Yasuo Ito; Masao Tomioka; Tetsuya Shimokawa; Yasuyuki Shiozaki; Tetsuro Mazaki; Masato Tanaka
Archives of Orthopaedic and Trauma Surgery | 2013
Tetsuro Mazaki; Yasuo Ito; Yoshihisa Sugimoto; Koichiro Koshimune; Masato Tanaka; Toshifumi Ozaki
Journal of Functional Foods | 2014
Tetsuro Mazaki; Takashi Kitajima; Yasuyuki Shiozaki; Miwa Sato; Megumi Mino; Aki Yoshida; Mariko Nakamura; Yasuhiro Yoshida; Masato Tanaka; Toshifumi Ozaki; Akihiro Matsukawa; Yoshihiro Ito
Acta Medica Okayama | 2016
Noriyuki Watanabe; Yoshihisa Sugimoto; Masato Tanaka; Tetsuro Mazaki; Shinya Arataki; Tomoyuki Takigawa; Masaki Kataoka; Toshiyuki Kunisada; Toshifumi Ozaki